Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Alfresa and Tanabe Seiyaku to comarket modafinil in Japan

April 4, 2006

Approvable letter for Xenazine in Huntington's disease-associated chorea

April 3, 2006

Recent patents report new treatments for depression, anxiety, sleep disorders, etc.

April 3, 2006

Lacosamide has clinically relevant effect in neuropathic pain

April 3, 2006

First clinical trial of gene therapy for muscular dystrophy now under way

April 3, 2006

IND cleared for clinical studies of NIC5-15 for Alzheimer's disease

April 3, 2006

Fast track designation for PTC-124 in Duchenne muscular dystrophy

April 3, 2006

Eisai and DNAVEC collaborate on Alzheimer's disease vaccine

April 3, 2006

Reinitiation of Tysabri clinical trial dosing in multiple sclerosis

April 3, 2006

Provigil granted six months of pediatric exclusivity

April 3, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...